Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · 2C-I

2C-I in Trinidad and Tobago: not individually verified

Not individually verified

We have not confirmed that 2C-I specifically is scheduled in Trinidad and Tobago, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. Searches for 2c-i, 2ci, 2c-1 and iodo, and for every name beginning 2C, found no entry for 2C-I. The only iodo row is the one Legal Notice No. 345 of 2019 added to the Schedule I table, printed in the text layer as «251-NBOMe» and «2C-1-NBOMe», with the chemical name «2-(4-iodo-2,5-» «dimethoxyphenyl)-N-(2-» «methoxyphenyl)ethanamine». Whatever the character printed as 1 is taken to be, that chemical name puts a substituent on the nitrogen, and 2C-I is understood to be 4-iodo-2,5-dimethoxyphenethylamine with none, a chemical fact brought from outside the text, so the row does not name it. The row «2C-B» in the Schedule II table names the bromo compound, and the Second Schedule clause on salts and stereoisomers does not reach a different compound. The substance is not listed by name in any Schedule read, as at 3 October 2026, the date the instruments were read.

Confirm directly with Trinidad and Tobago’s national drug authority or your own embassy before you rely on anything.

What Trinidad and Tobago HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.